Regulatory evidence record
Filing 2026038713
Verify the regulatory disclosure, the connected issuer and person, and every normalized transaction derived from this filing.
InitialEffective
OTHER
Reported buys
€6,075.00
Reported sales
€0.00
Other reported value
€0.00
Buy/sale net
€6,075.00
Total reported value
€6,075.00
Normalized transactions
1
Connected evidence
Issuer and reporting person
The filing connects a reporting person, their disclosed role, and the issuer named in the regulatory record.
Issuer
PHARMA MAR, S.A.- Jurisdiction
- ES
- Issuer ID
- issuer:es:959800QWKZ45ZQC2AV58
Reporting person
SOLEDAD CUENCA MIRANDA- Original role label
- CONSEJERA
- Person ID
- insider:es:soledadcuencamiranda
Normalized transaction ledger
Transactions
Exact values remain visible alongside source direction, normalized nature, instrument, settlement, and venue. These records are normalized facts, not investment recommendations.
| Date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 12 Mar 2026 | CompraBUY | UNKNOWN | UNKNOWN | UNKNOWN | 75 | €81.00 | €6,075.00 | UNKNOWN |
Compra
UNKNOWN · UNKNOWN · UNKNOWN · UNKNOWN
Audit trail
Source provenance
Original authority records and the technical evidence behind this normalized resource.
| Source | Record | Observed | Quality | Original |
|---|---|---|---|---|
| CNMV · Spain | 2026038713 | 12 Jul 2026 | Passed |
Technical evidence for 2026038713Documents, pipeline versions, checksums, and quality notes
- Observed
- 12 Jul 2026
- Fetched
- 12 Jul 2026
- Parser
- legacy-cnmv-v1
- Mapping
- legacy-cnmv-v1
- Source schema
- legacy-cnmv-v1
- Payload SHA-256
- 00017fed406d…d39e7e1c8c0d
Source documents
| Document | Role | SHA-256 | Original |
|---|---|---|---|
| Primary disclosure | Primary disclosure | 8a1162c3c93d6427398c5f8938163f84d661e85ade359e524afc4d63e2661dd9 | Open document |
Quality outcomes
- LEGACY_NORMALIZATION_PRESERVED · PASS
Known limitations
- Historical completeness is source-dependent.